Increased incidence and characteristics of alveolar echinococcosis in patients with immunosuppression-associated conditions

Clinical Infectious Diseases

Volumn 59, Issue 8, 2014, Pages 1095-1104

  Chauchet, Adrien ^a,b   Grenouillet, Frédéric ^a,e,i   Knapp, Jenny ^a,e,i   Richou, Carine ^a,i   Delabrousse, Eric ^a,i   Dentan, Charlotte ^c   Millon, Laurence ^a,e,i   Di Martino, Vincent ^a,f,i   Contreras, Remy ^d,i   Deconinck, Eric ^b,g   Blagosklonov, Oleg ^a,h,i   Vuitton, Dominique A ^a,i   Bresson Hadni, Solange ^a,e,i   Vitrat, Virginie ⁱ   Bardonnet, Karine ⁱ   Bartholomot, Brigitte ⁱ   Beurton Chataigner, Isabelle ⁱ   Brientini, Marie Pascale ⁱ   Cappelle, Sylvie ⁱ   Evrard, Philippe ⁱ   Felix, Sophie ⁱ   Giraudoux, Patrick ⁱ   Heyd, Bruno ⁱ   Valmary Degano, Séverine ⁱ   Koch, Stéphane ⁱ   Mantion, Georges ⁱ   Raoul, Francis ⁱ   Vanlemmens, Claire ⁱ   Vuitton, Lucine ⁱ   Prost, Patricia ⁱ   Godet, Claire ^j   Abergel, Armand ⁱ   Beytout, Jean ⁱ   Cambon, Monique ⁱ   Besancenot, Jean François ⁱ   Cusenier, Bernadette ⁱ   Hillon, Patrick ⁱ   Minello, Anne ⁱ   Faure, Odile ⁱ   Letoublon, Christian ⁱ   Dumortier, Jérôme ⁱ   Guillaud, Olivier ⁱ   Partensky, Christian ⁱ   Rabodonirina, Meja ⁱ   Wallon, Martine ⁱ   Piarroux, Martine ⁱ   Chatelain, Eric ⁱ   Johann, Marc ⁱ   Raabe, Jean Jacques ⁱ   Sondag, Daniel ⁱ   Gerard, Alain ⁱ   Letranchant, Lorraine ⁱ   Machouart, Marie ⁱ   Watelet, Jérôme ⁱ   Farges, Olivier ⁱ   Samuel, Didier ⁱ   Chemla, Cathy ⁱ   Delattre, Jean Francois ⁱ   Guerin, Bruno ^k   Debruyne, Monique ^l   Abou Bacar, Ahmed ⁱ   Audet, Maxime ⁱ   Hansmann, Yves ⁱ   Lefebvre, Nicolas ⁱ   Alby Lepresle, Blandine ^m   more..

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^b UNIVERSITY HOSPITAL OF BESANÇON   (France)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

^d GESC Dept   (France)

^e University of Franche Comté   (France)

^f Hôpital Saint Jacques   (France)

^g UMR 1098 Graft tumor host Interactions and Cell and Tissue Engineering   (France)

^h Centre Hospitalier Universitaire de Besançon   (France)

ⁱ Annecy ^*  (France)

^j Charleville Mézière   (France)

^k Charleville Mézière ^*  (France)

^l Saint Ouen L Aumône   (France)

^m Saint Ouen L Aumône ^*  (France)

more..

Author keywords

Biotherapy; Cancer; Echinococcus multilocularis; Liver abscess; Liver metastases

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBENDAZOLE; ASPARTATE AMINOTRANSFERASE; BENZIMIDAZOLE; C REACTIVE PROTEIN; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; MEBENDAZOLE; SULFOXIDE;

ABDOMINAL PAIN; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ADVANCED CANCER; ADVERSE OUTCOME; AGED; ALOPECIA; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECHINOCOCCOSIS; FEMALE; HEMATOLOGIC MALIGNANCY; HEPATOGRAPHY; HIGH RISK PATIENT; HUMAN; IMAGE ANALYSIS; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INCIDENTAL FINDING; INFLAMMATORY DISEASE; LIVER ABSCESS; LIVER GRAFT; LIVER HEMANGIOMA; LIVER HEMATOMA; MALE; METASTASIS; NEOPLASM; NEUTROPENIA; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PRURITUS; RASH; RISK ASSESSMENT; RISK FACTOR; SEROLOGY; SIDE EFFECT; SOLID TUMOR; TREATMENT DURATION; DELAYED DIAGNOSIS; ECHINOCOCCOSIS, HEPATIC; IMMUNOCOMPROMISED PATIENT; MIDDLE AGED;

AGED; DELAYED DIAGNOSIS; ECHINOCOCCOSIS, HEPATIC; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; INCIDENCE; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS;

EID: 84919634836     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu520     Document Type: Article

References (34)

1. Kern P. Clinical features and treatment of alveolar echinococcosis. Curr Opin Infect Dis 2010; 23:505-12.
2. Vuitton DA,Wang Q, Zhou HX, et al. A historical view of alveolar echinococcosis, 160 years after the discovery of the first case in humans: part 1. What have we learnt on the distribution of the disease and on its parasitic agent? Chin Med J (Engl) 2011; 124:2943-53.
3. Kern P, Bardonnet K, Renner E, et al. European echinococcosis registry: human alveolar echinococcosis, Europe, 1982-2000. Emerg Infect Dis 2003; 9:343-9.
4. Romig T. Echinococcus multilocularis in Europe-state of the art. Vet Res Commun 2009; 33(suppl 1):31-4.
5. Torgerson PR, Keller K, Magnotta M, Ragland N. The global burden of alveolar echinococcosis. PLoS Negl Trop Dis 2010; 4:e722.
6. Bruzinskaite R, Marcinkute A, Strupas K, et al. Alveolar echinococcosis, Lithuania. Emerg Infect Dis 2007; 13:1618-9.
7. Catalano S, Lejeune M, Liccioli S, et al. Echinococcus multilocularis in urban coyotes, Alberta, Canada. Emerg Infect Dis 2012; 18:1625-8.
8. Peregrine AS, Jenkins EJ, Barnes B, et al. Alveolar hydatid disease (Echinococcus multilocularis) in the liver of a Canadian dog in British Columbia, a newly endemic region. Can Vet J 2012; 53:870-4.
9. Storandt ST, Kazacos KR. Echinococcus multilocularis identified in Michigan with additional records from Ohio. J Parasitol 2012; 98:891-3.
10. Vuitton DA, Gottstein B. Echinococcus multilocularis and its intermediate host: a model of parasite-host interplay. J Biomed Biotechnol 2010; 2010:923193.
11. Koch S, Bresson-Hadni S, Miguet JP, et al. Experience of liver transplantation for incurable alveolar echinococcosis: a 45-case European collaborative report. Transplantation 2003; 75:856-63.
12. Kaplan JE, Benson C, Holmes KK, Brooks JT, Pau A, Masur H. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009; 58:1-207; quiz CE1-4.
13. Gruener B, Cretu C, Brunetti E, et al. Accelerated larval growth of Echinococcus spp. in the immunodeficient host? [abstract]. Am J Trop Med Hyg 2008; 6:118.
14. Kayacan SM, Vatansever S, Temiz S, et al. Alveolar echinococcosis localized in the liver, lung and brain. Chin Med J (Engl) 2008; 121:90-2.
15. Gaultier JB, Hot A, Mauservey C, Dumortier J, Coppere B, Ninet J. Granulomatous liver disease as the presenting feature of alveolar echinococcosis in an hepatitis C infected cardiac transplant patient [in French]. Rev Med Interne 2009; 30:812-5.
16. Geyer M, Wilpert J, Wiech T, et al. Rapidly progressive hepatic alveolar echinococcosis in an ABO-incompatible renal transplant recipient. Transpl Infect Dis 2011; 13:278-84.
17. Weiner SM, Krenn V, Koelbel C, Hoffmann HG, Hinkeldey K, Ockert D. Echinococcus multilocularis infection and TNF inhibitor treatment in a patient with rheumatoid arthritis. Rheumatol Int 2011; 31: 1399-400.
18. Dentan C, Mazet R, Gilson M, Marchou-Lopez S, Gaudin P. Rheumatoid arthritis, alveolar echinococcosis, and rituximab: a case report. Joint Bone Spine 2012; 79:325-7.
19. Piarroux M, Piarroux R, Giorgi R, et al. Clinical features and evolution of alveolar echinococcosis in France from 1982 to 2007: results of a survey in 387 patients. J Hepatol 2011; 55:1025-33.
20. Bresson-Hadni S, Vuitton DA, Bartholomot B, et al. A twenty-year history of alveolar echinococcosis: analysis of a series of 117 patients from eastern France. Eur J Gastroenterol Hepatol 2000; 12:327-36.
21. Brunetti E, Kern P, Vuitton DA. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop 2010; 114:1-16.
22. Piarroux M, Piarroux R, Knapp J, et al. Populations at risk for alveolar echinococcosis, France. Emerg Infect Dis 2013; 19:721-8.
23. Bart JM, Piarroux M, Sako Y, et al. Comparison of several commercial serologic kits and Em18 serology for detection of human alveolar echinococcosis. Diagn Microbiol Infect Dis 2007; 59:93-5.
24. Kern P,Wen H, Sato N, et al. WHO classification of alveolar echinococcosis: principles and application. Parasitol Int 2006; 55(suppl):S283-7.
25. Georges S, Villard O, Filisetti D, et al. Usefulness of PCR analysis for diagnosis of alveolar echinococcosis with unusual localizations: two case studies. J Clin Microbiol 2004; 42:5954-6.
26. Caoduro C, Porot C, Vuitton DA, et al. The role of delayed 18F-FDG PET imaging in the follow-up of patients with alveolar echinococcosis. J Nucl Med 2013; 54:358-63.
27. French National Cancer Plan 2003-2007. Available at: http://www.plancancer. gouv.fr/images/stories/fichiers/Historique/Plan-cancer-2003-2007-MILC.pdf. Accessed 21 February 2014.
28. Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 2002; 3:991-8.
29. Nam JL,Winthrop KL, van Vollenhoven RF, et al. Current evidence for the management of rheumatoid arthritis with biological diseasemodifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA. Ann Rheum Dis 2010; 69:976-86.
30. Kern P, Gruner B, Wahlers K. Diagnosis and course of echinococcocal diseases in the transplant setting. Transpl Infect Dis 2011; 13:217-21.
31. Brooks JT, Kaplan JE, Holmes KK, Benson C, Pau A, Masur H. HIVassociated opportunistic infections-going, going, but not gone: the continued need for prevention and treatment guidelines. Clin Infect Dis 2009; 48:609-11.
32. Bresson-Hadni S, Delabrousse E, Blagosklonov O, et al. Imaging aspects and non-surgical interventional treatment in human alveolar echinococcosis. Parasitol Int 2006; 55(suppl):S267-72.
33. Barth TF, Herrmann TS, Tappe D, et al. Sensitive and specific immunohistochemical diagnosis of human alveolar echinococcosis with the monoclonal antibody Em2G11. PLoS Negl Trop Dis 2012; 6:e1877.
34. Kadry Z, Renner EC, Bachmann LM, et al. Evaluation of treatment and long-term follow-up in patients with hepatic alveolar echinococcosis. Br J Surg 2005; 92:1110-6.